Journal for ImmunoTherapy of Cancer (Nov 2023)

222-G Beyond PD-L1: unraveling the enigma of immunotherapy response in PD-L1 negative (

Juan Gumuzio,
Lissete Sanchez-Magraner,
James Miles,
Fernando Aguirre,
Peter J Parker,
Veronique Calleja

Affiliations

Juan Gumuzio: 1HAWK Biosystems, Derio, Bizkaia, Spain
Lissete Sanchez-Magraner: 1HAWK Biosystems, Derio, Bizkaia, Spain
James Miles: 1HAWK Biosystems, Derio, Bizkaia, Spain
Fernando Aguirre: 1HAWK Biosystems, Derio, Bizkaia, Spain
Peter J Parker: 1HAWK Biosystems, Derio, Bizkaia, Spain
Veronique Calleja: 1HAWK Biosystems, Derio, Bizkaia, Spain

DOI: https://doi.org/10.1136/jitc-2023-SITC2023.0222-G
Journal volume & issue: Vol. 11, no. Suppl 2

Abstract

No abstracts available.

Published in Journal for ImmunoTherapy of Cancer

ISSN: 2051-1426 (Online)
Publisher: BMJ Publishing Group
Country of publisher: United Kingdom
LCC subjects: Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens
Website: https://jitc.bmj.com

About the journal